Physician profile
Michael J Carr
NPI 1396286621
$516.49
in general payments reported to CMS, 2019-2025
9 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $123 · 2024: $73.79 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239 · Education: $93.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.24 |
| Education | $93.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $167.60 | 2022 | |
| Abbvie INC. | $102.20 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Medical Device Business Services, INC. | $93.00 | 2025 | |
| Atricure, INC. | $42.48 | 2025 | Synergy Ablation System |
| Baxter Healthcare | $30.15 | 2024 | Floseal |
| Avita Medical Americas, LLC | $24.48 | 2024 | |
| Cerus Corporation | $20.77 | 2023 | Intercept Blood System For Platelets |
| Polynovo North America LLC | $19.16 | 2024 | Novosorb Btm |
| Merck Sharp & Dohme LLC | $16.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.